Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis.

Jan G. C. van Amsterdam,Gjalt-Jorn Peters,Ed Pennings,Tom Blickman,Kaj Hollemans,J J Breeksema,Johannes G. Ramaekers,Cees Maris,Floor van Bakkum,Ton Nabben,Willem Scholten,Tjibbe Reitsma,Judith Noijen,Raoul Koning,Wim van den Brink

Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis.

2021

Jan G. C. van Amsterdam
Gjalt-Jorn Peters
Ed Pennings
Tom Blickman
Kaj Hollemans
J J Breeksema
Johannes G. Ramaekers
Cees Maris
Floor van Bakkum
Ton Nabben
Willem Scholten
Tjibbe Reitsma
Judith Noijen
Raoul Koning
Wim van den Brink

Background:Ecstasy (3,4-methylenedioxymethamphetamine (MDMA)) has a relatively low harm and low dependence liability but is scheduled on List I of the Dutch Opium Act (‘hard drugs’). Concerns surro...

Keywords:

Ecstasy
Harm
Decision analysis
Opium
Multiple-criteria decision analysis
Psychology
Risk assessment
MDMA
Psychiatry
Liability

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations